SCT scientists develop Neo-Islet technology for treating insulin-dependent diabetes
News-Medical.net The cover of the July 2017 issue of the journal STEM CELLS Translation Medicine showcases the latest advance toward a functional cure of insulin-dependent diabetes. Scientists at SymbioCellTech (SCT), a small biotech company in Salt Lake City, ... |
Social Plugin